Taira Y, Panagia V, Shah K R, Beamish R E, Dhalla N S
Division of Cardiovascular Sciences, St. Boniface General Hospital Research Centre, Winnipeg, Manitoba, Canada.
Circ Res. 1990 Jan;66(1):28-36. doi: 10.1161/01.res.66.1.28.
Phosphatidylethanolamine (PtdEtn) N-methyltransferase activities were studied in rat heart sarcolemmal and sarcoplasmic reticular fractions after a single intraperitoneal injection of isoproterenol (0.5-5.0 mg/kg). Three active sites (I, II, and III) for PtdEtn N-methylation were assayed by measurement of [3H]methyl group incorporation from 0.055, 10, and 150 microM S-adenosyl-L-[methyl-3H]methionine into membrane PtdEtn molecules. Total methylation activity for catalytic site I of both sarcolemma and sarcoplasmic reticulum was stimulated within 2 minutes by isoproterenol in a dose-dependent manner. Although the increased methyltransferase activity in sarcoplasmic reticulum was normalized at 10 minutes, the enzyme activity in sarcolemma was normalized at 5 minutes but was again increased at 10-30 minutes after isoproterenol injection. No changes in response to isoproterenol were seen for site II and III N-methylation activities in either membrane. Individual N-methylated phospholipids (phosphatidyl-N-monomethylethanolamine, phosphatidyl-N,N-dimethylethanolamine, and phosphatidylcholine), which specifically formed at each site, showed similar behavior. Pretreatment of the animals with a beta-blocking drug, atenolol, for 2 days prevented the isoproterenol-induced changes in hemodynamic parameters and sarcolemmal methylation without affecting the enhanced methylation activities in sarcoplasmic reticulum. In vitro addition of cyclic AMP-dependent protein kinase (catalytic subunit) plus Mg-ATP enhanced methyltransferase activities in sarcolemma and sarcoplasmic reticulum from control hearts by 2.7- and 2.3-fold, respectively; however, under the same in vitro conditions, only about 20% activation was seen in both subcellular membranes isolated from the heart of isoproterenol-injected animals.(ABSTRACT TRUNCATED AT 250 WORDS)
在大鼠腹腔注射一次异丙肾上腺素(0.5 - 5.0毫克/千克)后,对大鼠心脏肌膜和肌浆网部分的磷脂酰乙醇胺(PtdEtn)N - 甲基转移酶活性进行了研究。通过测量从0.055、10和150微摩尔S - 腺苷 - L - [甲基 - ³H]甲硫氨酸掺入膜PtdEtn分子中的[³H]甲基基团,测定了PtdEtn N - 甲基化的三个活性位点(I、II和III)。异丙肾上腺素在2分钟内以剂量依赖的方式刺激了肌膜和肌浆网催化位点I的总甲基化活性。虽然肌浆网中增加的甲基转移酶活性在10分钟时恢复正常,但肌膜中的酶活性在5分钟时恢复正常,但在注射异丙肾上腺素后10 - 30分钟再次升高。两种膜中位点II和III的N - 甲基化活性对异丙肾上腺素均无反应变化。在每个位点特异性形成的单个N - 甲基化磷脂(磷脂酰 - N - 单甲基乙醇胺、磷脂酰 - N,N - 二甲基乙醇胺和磷脂酰胆碱)表现出类似的行为。用β - 受体阻滞剂阿替洛尔对动物进行2天预处理,可防止异丙肾上腺素诱导的血流动力学参数和肌膜甲基化变化,而不影响肌浆网中增强的甲基化活性。体外添加环磷酸腺苷依赖性蛋白激酶(催化亚基)加Mg - ATP可使对照心脏的肌膜和肌浆网中的甲基转移酶活性分别提高2.7倍和2.3倍;然而,在相同的体外条件下,从注射异丙肾上腺素的动物心脏分离的两种亚细胞膜中仅观察到约20%的激活。(摘要截断于250字)